Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Truist Securities Maintains Buy on Axonics, Raises Price Target to $85

Truist Securities analyst Richard Newitter maintains Axonics (NASDAQ:AXNX) with a Buy and raises the price target from $75 to $85.
byBenzinga Newsdesk
August 2, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Truist Securities analyst Richard Newitter maintains Axonics (NASDAQ:AXNX) with a Buy and raises the price target from $75 to $85.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Expert Ratings For Ecolab

By Benzinga Insights
March 17, 12:01 PM
Over the past 3 months, 9 analysts have published their opinion on Ecolab (NYSE:ECL) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

ECL